Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:advertising |
growth and expansion
|
| gptkbp:businessModel |
biopharmaceutical development
|
| gptkbp:CEO |
gptkb:Dr._Yung_Chi
|
| gptkbp:clinicalTrials |
ongoing
data-driven decisions targeted therapies solid tumors treatment development hematological malignancies immune checkpoint inhibitors patient trials promising results Phase 2 studies Phase 1/2 broad spectrum |
| gptkbp:collaborations |
academic institutions
biopharmaceutical companies academic research centers leading universities |
| gptkbp:community_service |
community engagement
overall survival progression-free survival predictive indicators |
| gptkbp:enrollment |
diverse demographics
|
| gptkbp:feedback |
improved survival rates
|
| gptkbp:focus |
immuno-oncology
|
| gptkbp:founded |
2012
|
| gptkbp:funding |
multiple
grants and investments |
| gptkbp:headquarters |
gptkb:San_Carlos,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Apexigen
|
| gptkbp:innovation |
cancer immunotherapy
|
| gptkbp:investmentFocus |
$100 million
Venture capital firms |
| gptkbp:leads |
APX005M
|
| gptkbp:market |
cancer therapeutics
|
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:notableFeature |
novel therapies
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
research collaborations |
| gptkbp:platforms |
proprietary technology
|
| gptkbp:products |
APX005M
|
| gptkbp:publications |
peer-reviewed journals
|
| gptkbp:reach |
international partnerships
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
compliance_with_FDA |
| gptkbp:research |
cancer treatment
advancing knowledge novel treatments |
| gptkbp:research_areas |
combination therapy
oncology cutting-edge research various stages immune modulation |
| gptkbp:research_focus |
tumor microenvironment
|
| gptkbp:supportRole |
experts in oncology
|
| gptkbp:targets |
CTLA-4
PD-1 |
| gptkbp:team |
experienced professionals
|
| gptkbp:technology |
monoclonal antibodies
|
| gptkbp:tributaryOf |
multiple candidates
|
| gptkbp:vision |
transform cancer treatment
|
| gptkbp:website |
www.apexigen.com
|